Tuesday, 17 November 2026
Market

Bayer raises 2026 profit outlook on strong pharmaceuticals performance

Bayer raised its 2026 profit outlook after its pharmaceuticals division delivered stronger-than-expected third-quarter sales. The German group also lowered its debt forecast, signalling improving growth momentum and a stronger financial position.

Summarise with AI
Bayer raises 2026 profit outlook on strong pharmaceuticals performance

German pharmaceuticals and agriculture group Bayer on Tuesday raised its 2026 profit outlook, citing stronger-than-expected performance in its pharmaceuticals business, which delivered sales above market estimates in the third quarter, Reuters reported.

The company now expects adjusted core earnings, on a currency-adjusted basis, to reach between 9.8 billion euros and 10.3 billion euros in 2026. This compares with its previous forecast of 9.6 billion euros to 10.1 billion euros.

as a Reliable and Trusted News Source

(You can now subscribe to our ETMarkets WhatsApp channel)

BayerBayer profit outlookpharmaceuticals businessQ3 salesadjusted earningsBill AndersonGerman pharmaceuticalsfinancial debtearnings forecastagriculture business

(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .)

Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price

#bayer#bayer profit outlook#pharmaceuticals business#q3 sales#adjusted earnings#bill anderson

Source: ET Markets

Disclaimer: This article is for general information and does not constitute investment, tax or legal advice. Markets and rates change; please verify with official sources or a qualified professional before you act.

Newsletter

Stay ahead of the market.

Get The Daily every morning: the day’s banking, markets and economy stories and stock data as a digital newspaper, plus free access to our money tools. Unsubscribe any time.